FDA could approve drugs for new uses on less data draft law

Apr 30, 2015, 00:00 by Michael Croft

Reuters | A bill drafted by the House Energy & Commerce Committee's health panel would eliminate the need for randomized, controlled clinical trials, the gold standard for assessing whether a product is safe and effective.

April 30, 2015 | A bill drafted by the House Energy & Commerce Committee's health panel would eliminate the need for randomized, controlled clinical trials, the gold standard for assessing whether a product is safe and effective. Reuters